Mechanism of action of everolimus in renal cell carcinoma

This publication has 51 references indexed in Scilit:

• Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
  Published by Elsevier ,2008
• Emerging drugs for the treatment of metastatic renal cancer
  Emerging Drugs, 2007
• Treatment options in renal cell carcinoma: past, present and future
  Annals of Oncology, 2007
• The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy
  Clinical Cancer Research, 2007
• Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
  New England Journal of Medicine, 2007
• Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma
  The American Journal of Pathology, 2006
• Androgens Induce Prostate Cancer Cell Proliferation through Mammalian Target of Rapamycin Activation and Post-transcriptional Increases in Cyclin D Proteins
  Cancer Research, 2006
• The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation
  Cell, 2005
• The Genetic Basis of Cancer of the Kidney
  Journal of Urology, 2003
• Regulation of Hypoxia-Inducible Factor 1α Expression and Function by the Mammalian Target of Rapamycin
  Molecular and Cellular Biology, 2002